Khiron’s portfolio of more than 20 THC and CBD strains already registered with the Colombian Agricultural Institute (ICA), is key to building agronomic and chemical profiles to treat a variety of medical conditions.
At the core of Khiron’s wellness unit, Kuida® cosmeceuticals, the first mass-market branded CBD skincare line in Latin America, is distributed at retail and online across Colombia and in permissive Stated in the United States.
Khiron will introduce the Aceso™ Hemp brand to the Latin America market, with initial sales beginning in Q4 2019 in Colombia.
Learn moreOur goals go beyond building a great cultivation facility. We aim to become the global leader in creating high quality, consumer packaged goods (CPG) cannabis brands around the world.
With regulatory change happening rapidly across Latin America, eleven countries have legalized medical cannabis, and three have decriminalized the use of personal amounts. With operations in Colombia, a presence in Mexico, Uruguay, Chile and Peru, and access to Brazil, Khiron Life Sciences is positioned to be a leading, established player providing investor exposure to the Latin American market.
Our experienced European management team provides Khiron with a strong cannabis industry background in capital markets and regulatory matters. The company currently has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida® products to be launched in the UK. The company has also entered into an agreement to be the exclusive Latin American provider of cannabis medicines to Project Twenty21 in the UK. The company is set for growth in Europe, with significant near- and long-term revenue opportunities thatvalidate the company's management, execution abilities and global strategy.
We’re proud to be partnering with international brands that share our passion. Learn more about how our CPG brands around the world make a difference.
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab include full capabilities in Ultra high and High performance liquid chromatography ("UHPLC" & "HPLC") technology, gas chromatography, stability testing, microbiology and heavy metals testing.
Physical chemical cannabis testing lab has a capacity of up to 70 daily UHPLC & HPLC cannabinoid samples, 15 daily gas chromatography samples, and 2,000 monthly heavy metals samples. Microbiological testing lab has a capacity of up to 20 daily samples.
State-of-the-art testing lab allows the Company to fully test every aspect of its vertical integration from soil and water, to flower to extract, ensuring a high-quality product that will be delivered to patients across Latin America.
Cultivation capabilities operate within the most up-to-date country THC quotas assigned by the International Narcotics Control Board (INCB) to meet domestic demand, including treatment of more than 119,000 patients at the Company's ILANS clinics.
Khiron Life Sciences has a highly experienced management team and influential board representation including the 55th president of Mexico and former CEO of Coca Cola Mexico, Vicente Fox, and global retail brand entrepreneur Joseph Mimran who sits on the board of the Company’s Colombia subsidiary
Have business-related questions about KHRN? Or just general inquiries? Send us a message and we ́ll be happy to help.
